张雪问谁不服

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that glob

ations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior foreca

当前文章：http://o7scug.taoqiayu.cn/9mk/igl0yi2.html

发布时间：21:46:46